CY1117389T1 - HYDROSYL-SUBSTITUTED PYROLID [2,3-b] PYRIDINES AND PYROLID [2,3-b] PYRAMIDINES AS JANUS MOVEMENTS - Google Patents

HYDROSYL-SUBSTITUTED PYROLID [2,3-b] PYRIDINES AND PYROLID [2,3-b] PYRAMIDINES AS JANUS MOVEMENTS

Info

Publication number
CY1117389T1
CY1117389T1 CY20161100097T CY161100097T CY1117389T1 CY 1117389 T1 CY1117389 T1 CY 1117389T1 CY 20161100097 T CY20161100097 T CY 20161100097T CY 161100097 T CY161100097 T CY 161100097T CY 1117389 T1 CY1117389 T1 CY 1117389T1
Authority
CY
Cyprus
Prior art keywords
pyrolid
janus
pyridines
pyramidines
hydrosyl
Prior art date
Application number
CY20161100097T
Other languages
Greek (el)
Inventor
James D Rodgers
Stacey Shepard
Thomas P Maduskuie
Haisheng Wang
Nikoo Falahatpisheh
Maria Rafalski
Argyrios G Arvanitis
Louis Storace
Ravi Kumar Jalluri
Original Assignee
Incyte Holdings Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11152677.8A external-priority patent/EP2343299B9/en
Application filed by Incyte Holdings Corporation filed Critical Incyte Holdings Corporation
Publication of CY1117389T1 publication Critical patent/CY1117389T1/en

Links

Abstract

Η παρούσα εφεύρεση παρέχει ετεροαρυλο υποκατεστημένες πυρρολο[2,3-b]πυριδίνες (I) και ετεροαρυλο υποκατεστημένες πυρρολο[2,3-b]πυριμιδίνες που διαμορφώνουν τη δραστικότητα κινασών Janus και είναι χρήσιμες στη θεραπευτική αγωγή νόσων που σχετίζονται με τη δραστικότητα κινασών Janus συμπεριλαμβανομένων, για παράδειγμα, ανοσοσχετιζόμενων νόσων, δερματικών διαταραχών, μυελοειδών βλαστικών διαταραχών, καρκίνου, και άλλων νόσων.The present invention provides heteroaryl substituted pyrrolo [2,3-b] pyridines (I) and heteroaryl substituted pyrrolo [2,3-b] pyrimidines that modulate Janus kinase activity and are useful in the treatment of Janus activity-related diseases including, for example, immunosuppressive diseases, skin disorders, myeloid stem cells, cancer, and other diseases.

CY20161100097T 2005-12-13 2016-02-03 HYDROSYL-SUBSTITUTED PYROLID [2,3-b] PYRIDINES AND PYROLID [2,3-b] PYRAMIDINES AS JANUS MOVEMENTS CY1117389T1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US74990505A 2005-12-13 2005-12-13
US81023106A 2006-06-02 2006-06-02
US85062506A 2006-10-10 2006-10-10
US85687206A 2006-11-03 2006-11-03
US85940406A 2006-11-16 2006-11-16
EP11152677.8A EP2343299B9 (en) 2005-12-13 2006-12-12 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

Publications (1)

Publication Number Publication Date
CY1117389T1 true CY1117389T1 (en) 2017-04-26

Family

ID=58606651

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100097T CY1117389T1 (en) 2005-12-13 2016-02-03 HYDROSYL-SUBSTITUTED PYROLID [2,3-b] PYRIDINES AND PYROLID [2,3-b] PYRAMIDINES AS JANUS MOVEMENTS

Country Status (2)

Country Link
CY (1) CY1117389T1 (en)
HK (1) HK1168090A1 (en)

Also Published As

Publication number Publication date
HK1168090A1 (en) 2012-12-21

Similar Documents

Publication Publication Date Title
CY1112762T1 (en) HYDROSYL-SUBSTITUTED PYROLID [2,3-b] PYRIDINES AND PYROLID [2,3-b] PYRAMIDINES AS JANUS MOVEMENTS
CY1120257T1 (en) PYROLOL [2,3b] PYRIDIN-4-GLAMES AND PYROLOL [2,3b] PYRIMIDIN-4-GLAMES AS JANUS MODELS
CY1121021T1 (en) IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDES AS KINASE INHIBITORS
CY1117693T1 (en) JANUS (R) -3- (4- (7H-PYRROLO [2,3-d] Pyrimidin-4-yl) -1H-pyrazol-1-yl) -3-CYCLIPLIN Crystalline Salts of JANUS (R) -3
CY1111996T1 (en) Pyrrolo [2,3-B] Pyridine Derivatives as Protein Kinase Inhibitors
NO20081349L (en) Pyrrolopyrimidine derivatives as Syk inhibitors
PA8637601A1 (en) MODULATING COMPOUNDS OF C-KIT ACTIVITY AND USES OF THE SAME
UY28970A1 (en) MODULATING COMPOUNDS OF C-KIT ACTIVITY AND USES OF THE SAME
MX2009006162A (en) Pyrrolo [2, 3-b] pyridine derivatives as kinase modulators.
EA200500721A1 (en) Pyrimidines inhibiting CHK, PDK and ACT, THEIR RECEIVING AND USING AS MEDICINES
PA8550101A1 (en) DERIVATIVES OF BENZAMIDA TIAZOL AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT THE PROLIFERATION OF CELLS, AND METHODS FOR USE
EA200800223A1 (en) PYRIDO [2,3-d] PYRIMIDINE DERIVATIVES, THEIR RECEIVING AND THEIR APPLICATION IN THERAPY
DK1423384T3 (en) Pyridine derivatives such as Raf kinase inhibitors
CY1112038T1 (en) Suspensions of tyrosine kinase
UA97629C2 (en) Pharmaceutical formulation exhibiting antitumor activity and methods
CY1117389T1 (en) HYDROSYL-SUBSTITUTED PYROLID [2,3-b] PYRIDINES AND PYROLID [2,3-b] PYRAMIDINES AS JANUS MOVEMENTS
EA202091616A2 (en) HETEROARYL SUBSTITUTED PYRROLO [2,3-b] PYRIDINES AND PYRROLO [2,3-b] PYRIMIDINES AS INHIBITORS OF JANUS KINASE
CY1117553T1 (en) Pyrrolo [2,3-B] Pyridine Derivatives as Protein Kinase Inhibitors
UA106617C2 (en) N- (hetero) arylpyrrolidine derivatives of pirazol-4-ylpyrrolo [2,3-d] pyrimidines and pyrrol-3-ylpyrrolo [2,3-d] pyrimidines as inhibitors